Aidapak Recalls Pioglitazone Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 15 mg Pioglitazone tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The hazard is a labeling error (label mixup) without reported injuries, fitting the Moderate severity criteria for minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling 90-count bottles of Pioglitazone 15 mg tablets (NDC 00591320530) due to a potential labeling error. The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall involves specific pedigree codes AD22845_1, AD25452_10, and AD28322_4, all with an expiration date of 4/30/2014.
The recall was initiated because the Pioglitazone tablets may have been mislabeled as Lactase Enzyme 3000 units, Phosphorus 250 mg, or Aripiprazole 15 mg. This label mixup could lead to patients receiving the wrong medication.
Patients and consumers who have these specific Pioglitazone tablets should stop using them and contact their healthcare provider or pharmacist for instructions on how to return the product or obtain a replacement.
The recalled product
- Product
- PIOGLITAZONE, Tablet, 15 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591320530.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- PIOGLITAZONE
- Tablet
- 15 mg has the following codes: Pedigree: AD22845_1
- EXP: 4/30/2014
- Pedigree: AD25452_10
- Pedigree: AD28322_4
- EXP: 4/30/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAidapak Recalls Propranolol HCL Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAripiprazole Tablets Recalled Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phytonadione Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- HighAidapak Recalls Mirtazapine Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phytonadione Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22